What momentous day!

We are delighted that the drug Elacestrant has been approved by NICE for patients with oestrogen receptor (ER)-positive HER2-negative metastatic breast cancer with ESR1 mutation that has progressed after at least 12 months of treatment with endocrine therapy and a CDK 4/6

Day 4, joined by Sharon Tom Scrupps Tim White for a walk along the river Slea, another 15.4km completed, that’s 40km in the last 4 days supporting BreastCancer100 and CoppaFeel! any donations to support this fantastic charity are greatly appreciated by the team.

On behalf of all the Trustees, volunteers and supporters of METUPUK, we would like to offer our heartfelt congratulations to our Founder, Jo Taylor, for being awarded the British Empire Medal in The King's New Year Honours List 2025. A much deserved recognition for years of work

2024 was another heartbreaking year for the loss of so many amazing women to metastatic/secondary breast cancer. My thoughts and love go to all of their families and friends. We need investment and access to the latest drugs and treatments to survive longer. I hope we see some

Yesterday, I spoke with BBC Lancashire to talk about living with a metastatic breast cancer diagnosis. My cancer cannot be cured, but it can be treated and currently I have no evidence of disease. I am feeling well so it’s business as usual!

Thanks Kevin Scrupps and Pygott & Crone for organising and supporting the CoppaFeel! 100k fundraising event, Tracy Pratt and I have enjoyed taking part and more importantly helping to raise money for a charity close to our hearts.

Gary Pratt Kevin Scrupps Pygott & Crone Tracy Pratt We're so glad you enjoyed taking part! Thanks for helping us raise life saving funds 💕

On #WorldCancerDay we're sharing stories on Instagram to highlight some of the signs & symptoms patients felt before their secondary breast cancer diagnosis. GenesisCareUK research shows 1 in 3 people do not know what secondary breast cancer is & we're on a mission to change that.

One of the things we hear most about at METUPUK is what we ‘shouldn’t be’ with Metastatic Breast Cancer. Either we are too ill, not ill enough, have hair when we shouldn’t or any other list of things that MBC apparently isn’t. A week rarely goes by without a story of missed

Had a great time last night watching Bill Bailey on the last night of his show with Gary Pratt Lovely tribute to the great Sean Lock ❤️

Today is Rare Disease Day. Those who know me understand Joshua has an ultra rare genetic mutation in ATP1A3. Today was a day to feel the sun on my face and take a breath. We live with uncertainty every day and this takes on a huge toll on us as a family. #RareDiseaseDay

Secondary breast cancer (SBC) can be referred to in a number of ways, which can be confusing. They all mean the same. SBC is a cancer that has spread beyond the breast to other parts of the body. Find out more & how we support those living with it: make2ndscount.co.uk

“Your mummy loves you forever fund” 🩷 This is beautiful Hannah, my fellow Enhertu campaigner and an amazing woman, who has Stage 4 incurable cancer. Her dying wish is that her 4 year old daughter Lilah, who has complex needs, can be taken care of. Please support this GoFundMe

For Lilah 🩷 Please share and donate if you can X gofundme.com/f/hannahs-gift…

The SHOCKING Truth about Turmeric and Breast Cancer youtu.be/LqYG_sArBb4?si… via YouTube

METUPUK is delighted that the drug combination capivasertib plus fulvestrant has been recommended by NICE for patients with oestrogen receptor positive metastatic breast cancer who: · have progressed on hormonal treatment · have one or more PIK3CA, AKT1 or PTEN gene alterations

📢 Amazing news! NICE has recommended capivasertib with fulvestrant for use on the NHS in England – offering certain people with HR-positive secondary breast cancer a new targeted treatment option. breastcancernow.org/about-us/media…

Busy Living with Mets or on our knees waiting for the next treatment line... The public view of Metastatic Breast Cancer is more important than many realise - especially when it comes to campaigning for access to treatment, better interventions, and even practical matters like

A breast cancer drug that could extend the lives of hundreds of women is being withheld from the NHS in an escalation of a pricing row with the pharmaceutical industry ⬇️ thetimes.com/uk/healthcare/…